0000899243-21-028880.txt : 20210719 0000899243-21-028880.hdr.sgml : 20210719 20210719201709 ACCESSION NUMBER: 0000899243-21-028880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210719 FILED AS OF DATE: 20210719 DATE AS OF CHANGE: 20210719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Offer Andrew CENTRAL INDEX KEY: 0001870371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40587 FILM NUMBER: 211099154 MAIL ADDRESS: STREET 1: C/O SIGHT SCIENCES, INC. STREET 2: 4040 CAMPBELL AVENUE, SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sight Sciences, Inc. CENTRAL INDEX KEY: 0001531177 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 800625749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (415) 889-0550 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 3, SUITE 105 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-19 0 0001531177 Sight Sciences, Inc. SGHT 0001870371 Offer Andrew C/O SIGHT SCIENCES, INC. 4040 CAMPBELL AVE, SUITE 100 MENLO PARK CA 94025 1 0 0 0 Common Stock 2021-07-19 4 C 0 3162 A 3162 D Common Stock 2021-07-19 4 C 0 2225752 A 2355062 I See footnote Series C Preferred Stock 2021-07-19 4 C 0 1581 D Common Stock 3162 0 D Series A Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 1086956 D Common Stock 2173912 0 I See footnote Series B Redeemable Convertible Preferred Stock 2021-07-19 4 C 0 25920 D Common Stock 51840 0 I See footnote The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II. /s/ Jeremy Hayden, Attorney-in-Fact for Andrew Offer 2021-07-19